The largest database of trusted experimental protocols

Artelac rebalance

Manufactured by Bausch & Lomb
Sourced in United States, Germany

Artelac Rebalance is a sterile, preservative-free eye drop solution designed to provide hydration and relief for dry eyes. It contains hypromellose and glycerin to help maintain the natural tear film and soothe discomfort associated with dry eye condition.

Automatically generated - may contain errors

2 protocols using artelac rebalance

1

Mechanical Dissection for MyoRing Implantation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mechanical dissection using the Melles hook procedure of Myoring implantation involved making an incision in the steep axis of the cornea with 0.5 mm length (smaller than MyoRing diameter) using a diamond blade. Afterward, a dissection in 300 μm depth with 3 mm (bigger than MyoRing diameter) was created using a Melles hook. Subsequently, the MyoRing was inserted into the pocket, which was mechanically created in the cornea, and its proper centration was determined using a keratoscope.
In both surgical methods, it was observed that the created pocket was capable of self-sealing and did not require any suture. Eventually, a bandage contact lens (Bausch & Lomb) was placed on the cornea and MyoRing implantation surgery was completed using chloramphenicol (Sinadaru Laboratories, Iran) eye drops. The bandage contact lens was removed 1 day after surgery. Four drops per day of chloramphenicol and betamethasone (Sinadaru Laboratories, Iran) and six drops per day of preservative-free artificial tears (Artelac Rebalance, Bausch & Lomb, Inc., USA) were prescribed postoperatively. The chloramphenicol drop was interrupted 1 week after surgery while the betamethasone dosage was tapered off during 4–6 weeks. Also, Artelac was continued 6 times a day for 1 month.
+ Open protocol
+ Expand
2

Commonly Prescribed Artificial Tears in Germany

Check if the same lab product or an alternative is used in the 5 most similar protocols
Prior to entry into the study, a selection of patients were using commonly prescribed artificial tears in Germany. These included aqueous-based tears Hylo-Comod® (URSAPHARM Arneimittel GmbH, Saarbrücken, Germany), Wet-Comod® (URSAPHARM Arneimittel GmbH), Hylo-Vision® (OmniVision GmbH, Puchheim, Germany), Artelac Rebalance® (Bausch and Lomb, Inc., North Bridgewater, NJ, USA), Artelac Splash® (Bausch and Lomb, Inc.), Systane® (Alcon Laboratories Inc., Fort Worth, TX, USA), Systane Ultra® (Alcon Laboratories Inc.), Thealoz® (Spectrum Thea Pharmaceuticals, Ltd, Macclesfield, UK), Hyabak® (Spectrum Thea Pharmaceuticals, Ltd), and Vismed® (TRB Chemedica Int SA, Geneva, Switzerland), or lipid-based tears Artelac Lipids® (Bausch and Lomb, Inc.), Cationorm® (Santen Pharmaceutical Co, Ltd, Osaka, Japan), Tears Again® (OCuSOFT, Inc., Rosenberg, TX, USA), and Systane Balance® (Alcon Laboratories Inc.).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!